Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Head Europe is the European division of Shandong Head Group, a global leader in the production of cellulose ethers. The company provides high-performance Hydroxypropyl Methylcellulose (HPMC) and Methylcellulose (MC) under the Headcel brand, which are used as critical excipients in pharmaceutical coatings, binders, and controlled-release formulations. Additionally, through its subsidiary Healsee, it offers a comprehensive range of plant-based HPMC capsules for the pharmaceutical and nutraceutical sectors. The European office provides localized technical support, logistics, and regulatory compliance services to ensure high-quality supply chains for its regional partners. The company is notable for its vertical integration, managing the entire production chain from raw cellulose to finished capsule shells.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Head Europe.